Inflammatory bowel disease (IBD) Clinical Trials
Recruiting inflammatory bowel disease (ibd) studies with sites across the US, sourced from ClinicalTrials.gov and refreshed daily. Free to join — find one near you below.
Clinical trials study new ways to prevent, detect, or treat inflammatory bowel disease (ibd). Joining one can give you access to investigational treatments and close monitoring by a specialist research team — at no cost — while helping advance care for others. Below are recruiting inflammatory bowel disease (ibd) studies with sites across the US; use the location tools to find ones near you.
What to expect
- Screening first. The study team reviews your eligibility before anything else — there's no obligation to continue.
- Informed consent. You'll get a full explanation of the study, its potential risks and benefits, and can withdraw at any time.
- No cost to you. Study visits, tests, and the investigational treatment are covered; many studies reimburse travel.
Recruiting inflammatory bowel disease (ibd) trials
Digital Mind Body Intervention Among Black and Hispanic Patients Living With Inflammatory Bowel Disease
Ex Vivo Study of hAMSC Secretome in Inflammatory Bowel Disease: Effects on Inflammation and Fibrosis (TARGET)
Xylitol Use for Decolonization of C. Difficile in Patients With IBD
Developing a Self-Management Intervention to Improve Health Outcomes for Patients With Inflammatory Bowel Disease
Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
A Multi-Center Randomized Controlled Trial on the Impact of Disease Subtype-Based Active Video Education on Bowel Preparation Quality in Patients With Inflammatory Bowel Disease
IBDminds - Mapping the Influence of aNxiety and DepreSsion on IBD
Guselkumab for Overlap Inflammatory Bowel Disease and Spondyloarthritis
Duloxetine in Inflammatory Bowel Diseases
Development of the SC-IBD Self-Care Measurement Scale
A Database Study of Disease, Treatment Patterns and Healthcare Use in Children With Inflammatory Bowel Diseases in Korea
Anemia as Predictor of Outcome in IBD Pateints in Assuit University Hospitals
Thermal Measurements of the Gut With a Colonoscope Compatible Thermal Probe
Lipopolysaccharide Adsorption (Efferon LPS) in Patients With Ulcerative Colitis and Crohn Disease
Fecal Microbiota Transplantation in an Expanded Ulcerative Colitis Population
GenesiDol for the Management of Musculoskeletal Pain
REgulating Pain Through Neurofeedback in infLammatory Bowel diseasE and Musculoskeletal Dysfunction
Association Between Vitamin D Deficiency and Inflammatory Bowel Disease
Pentoxifylline in Patients With Ulcerative Colitis
Platelet Indices in Inflammatory Bowel Diseases
COMPARE - Pediatric Inflammatory Bowel Disease (PIBD)
Personalized Risk Estimation for Crohn's Disease (PRE-Crohn's): Implementation and Feasibility
Value of Speckle Tracking Echocardiography Inflammatory Bowel Disease Patients
MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease
Impact of a Human Origin Heat Inactivated Probiotic-Lactobacillus Paracasei D3.5 (LpD3.5) as Dietary Supplement on Gut Mucin and Intestinal Permeability in Adults With IBD
Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance
Spondylo-arthritis Screening Tool Among Patient Suffering From Inflammatory Bowel Disease
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Resting Energy Expenditure in Pediatric Patients With Inflammatory Bowel Disease (REE-MICI)
Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases
TOD-IBD: Empowering Patients On-Demand
Study on the Correlation and Consistency of Measuring Biologic Drug Plasma Concentrations Based on Different Detection Methods
Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis
Heart Rate Variability and Inflammatory Bowel Disease
Inflammatory Bowel Disease Cohort in Nantes
Remote Monitoring of Patients With an Inflammatory Bowel Disease Under no or Maintenance Therapy
BOOM-IBD2 Pivotal Clinical Trial
Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease
Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease
Utility of Random Biopsies in Patients With Inflammatory Bowel Disease
Endoscopically Placed Lumen-Apposing Metal Stents for the Treatment of Symptomatic Intestinal Strictures in Individuals With Inflammatory Bowel Disease
Investigation of the Correlation Between Polyamine Levels and Their Key Enzymatic Activities in Association With Inflammatory Bowel Disease Progression
Clinical Value of Intestinal Ultrasound in Predicting Clinical Relapse in Crohn's Disease Patients in Deep Remission: a Multicenter Prospective Observational Study
Study on Lipid Profile Changes in Plasma and Intestinal Mucosa of Patients With Inflammatory Bowel Disease
Inherited Thromophilia and Thrombotic Risks in Inflammatory Bowel Disease During Activity and Remission
Prevalence of Non-Alcoholic Fatty Liver Disease in Inflammatory Bowel Disease Patients
Nutrition and Clinical Outcomes in IBD
Colorectal Omics and OfCS Proteoglycans
Testing the Role of Anti-fungal Therapy in Improving the Response to Therapies for Crohn's Disease
Investigation of VAP-1 Expression and Tissue Blood Flow by PET-MRI in Patients With Crohn's Disease
Beta-Hydroxybutyrate Feasibility Treating IBD
AIRE-2 Device for Study of Breath Analysis in IBD
Acupuncture Reduces Relapse in Patients With Crohn's Disease: a Superiority Trial
Predicting IBD Treatment Outcomes With Gut Microbiome Analysis
Improving Outcomes and Reducing Disparities for Patients With Inflammatory Bowel Disease Through Epidemiology and Enhanced Disease Management
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Robotic Inflammatory Bowel Disease Development, Learning and Efficacy Study
Neural Circuit Mechanism of Inflammatory Bowel Disease Combined With Depression
Inflammatory bowel disease (IBD) clinical trials — common questions
Are inflammatory bowel disease (ibd) clinical trials free to join?
Yes. Participating in a inflammatory bowel disease (ibd) clinical trial is free — study-related visits, tests, and the investigational treatment are provided at no cost to you. Many studies also reimburse travel and time. You never pay to take part.
Who can join a inflammatory bowel disease (ibd) clinical trial?
Each inflammatory bowel disease (ibd) study sets its own eligibility criteria — typically based on age, medical history, current treatments, and overall health. Every trial listed here shows its criteria, and the study team confirms your eligibility before enrollment. You can review and apply to any that look like a fit.
How do I find a inflammatory bowel disease (ibd) trial near me?
Use the location controls above. We'll show recruiting inflammatory bowel disease (ibd) trials with sites near you, sorted by distance. You can widen the radius or share your exact location for the closest matches.
How many inflammatory bowel disease (ibd) trials are recruiting right now?
We're currently tracking roughly 41 recruiting inflammatory bowel disease (ibd) trials with US sites, sourced from ClinicalTrials.gov and refreshed daily.
Looking for a specific location? Browse trials by city and state.